THE BEST SIDE OF HEMGENIX

Number of eligible individuals: CDEC mentioned the uncertainty in the amount of individuals with moderately serious to serious hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some clients that are categorized as possessing mild or average disorder could possibly have a significant bleed